The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans

Lupus

Volumn 5, Issue 3, 1996, Pages 184-189

  Granados, J ^a   Vargas Alarcon G ^a   Andrade, F ^a   Melin Aldana, H ^a   Alcocer Varela, J ^a   Alarcon Segovia D ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Major histocompatibility complex (MHC); MHC haplotypes; Susceptibility; Systemic lupus erythematosus

Indexed keywords

HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEXICO; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029902771     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500304     Document Type: Article

References (48)

1. Morton RO, Gershwin ME, Brady C, Steinberg AD. The incidence of systemic lupus erythematosus in North American Indians. J Rheumatol 1976; 3: 186-90.
2. Fessel WJ. Systemic lupus erythematosus in the community: incidence, prevalence, outcome and first symptoms; the high prevalence in black women. Arch Intern Med 1974; 134: 1027-35.
3. Schur PH, Pandey JP, Fedrick JA. Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 828-30.
4. Whittingham S, Matthews JD, Schonfield MS, Tait B, MacKay IR. HLA and Gm genes in SLE. Tissue Antigens 1985; 21: 50-7.
5. Fedrick JA, Pandey JP, Chen Z, Fudenberg HH, Ainsworth SK, Dobson RL. Gm allotypes in blacks with systemic lupus erythematosus. Hum Immunol 1983; 8: 177-81.
6. Miyaka Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981; II: 493-7.
7. Wilson JG, Wong WW, Schur PH, Fearon DT. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 1982; 307: 981-6.
8. Schur PH, Meyer I, Garovoy M, Carpenter CB. Association between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. Clin Immunol Immunopathol 1982; 24: 263-75.
9. Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RH. Relationship between C4 null genes, HLA-D region antigens and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 1986; 81: 187-93.
10. Arnett FC, Reveille JD, Wilson RW, Provost TT, Bias WB. Systemic lupus erythematosus : current state of the genetic hypothesis. Semin Arthritis Rheum 1984; 14: 24-35.
11. Batchelor JR, Welch KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russell GI. Hydralazine induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1980; I: 1107-9.
12. Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL. B-lymphocyte alloantigens associated with systemic lupus erythematosus N Engl J Med 1978; 299: 515-18.
13. Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC. Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression and clinical features in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1031-40.
14. Sherak O, Smolen JS, Mayr WR. Prevalence of HLA-DR2 not increased in systemic lupus erythematosus (letter). N Engl J Med 1979; 301; 612.
15. Celada A, Barras L, Benzonana G, Jeannet M. Increased frequency of HLA-DRw3 in systemic lupus erythematosus. Tissue Antigens 1980; 15: 283-8.
16. Walport MJ, Black CM, Batchelor JR. The immunogenetics of SLE. Clin Rheum Dis 1982; 8: 3-21.
17. Fielder AHL, Walport NJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GRV. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 1983; 286: 425-8.
18. Gibofsky A, Winchester RJ, Patarroyo M, Fotino M, Kunkel HG. Disease associations of the Ia-like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med 1978; 148: 1728-32.
19. Black CM, Welsh KI, Fielder A, Hughes GRV, Batchelor JR. HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes. Tissue Antigens 1982; 19: 115-20.
20. Hauptmann G, Grosshans E, Heid E. Lupus erythemateux aigus et deficits hereditaires en complement: a propos d'un cas par deficit complet en C4. Ann Dermatol Venereol 1974; 101: 479-96.
21. Schur PH. Inherited complement component abnormalities. Annu Rev Med 1986; 37: 333-46.
22. Christiansen FT, Dawkins RL, Uko G, McCluskey J, Kay PH, Zilko PJ. Complement allotyping in SLE: association with C4A null. Aust NZ J Med 1983; 13: 483-8.
23. Kemp ME, Atkinson JP, Skanes VM, Levine RP, Chaplin DD. Deletion of C4A genes in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 1015-22.
24. Granados J, Olivares I, Melín H, Andrade F, Alarcón-Segovia D. Further evidence of the role of complement genotypes in the susceptibility to systemic lupus erythematosus obtained from Mexican family studies (Abstract). Arthritis Rheum 1987; 30(Suppl 4): S21.
25. Reveille JD, Arnett FC, Wilson RW, Bias WB, McLean RH. Null alleles of the fourth component of complement and HLA haplotypes in familial SLE. Immunogenetics 1985; 21: 299-311.
26. Wilson WA, Perez MC, Armatis PE. Partial C4A deficiency is associated with susceptibility to systemic lupus erythematosus in black Americans. Arthritis Rheum 1988; 31: 1171-5.
27. Goldstein R, Arnett FC, McLean RH, Bias WB, Duvic M. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 736-44.
28. Wilson WA, Perez MC. Complete C4B deficiency cardiolipin antibodies in Black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15: 1855-8.
29. Welch TR, Beischel LS, Balakrishnan K, Quinlan M, West CD. Major histocompatibility complex extended haplotypes in systemic lupus erythematosus. Dis Markers 1988; 6: 247-55.
30. Rantapa DS, Beckman G, Beckman L. Serum protein markers in systemic lupus erythematosus. Hum Hered 1988; 38: 44-7.
31. Olsen NL, Goldstein R, Arnett FC, Duvic M, Pollack M, Reveille JD. C4A gene deletion and HLA associations in Black Americans with systemic lupus erythematosus. Immunogenetics 1989; 30: 27-33.
32. Dunckley H, Gatenby PA, Hawkins B, Naitos S, Serjeantson SW. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in 3 ethnic groups. J Immunogenet 1987; 14: 209-18.
33. Lisker R, Pérez-Briceño R, Granados J, Babinsky V, DeRubens J, Armendares S, Buentello L. Gene frequencies and admixture estimates in a mexican city population. Am J Physical Anthropol 1986; 71: 203-7.
34. Lisker R, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in the State of Puebla, Mexico. Am J Physical Anthropol 1988; 76: 331-5.
35. Lisker R, Ramirez E, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican Urban Centers. Hum Biology 1990; 62: 791-801.
36. Taa EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1272-7.
37. Ray JG, Hare DB, Pedersen PD, Mulally DI. NI AID Manual of Tissue Typing Techniques. Bethesda, MD, HEW, NIH. 1976.
38. Bodmer WF, Batchelor JR, Bodmer JG, Festenstein H, Morris PJ (eds): Histocompatibility Testing 1977. Copenhagen, Munksgaard, 1978.
39. Alper CA, Boenisch T, Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 1972; 135: 68-80.
40. Awdeh ZL, Alper CA. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 1980; 77: 3576-80.
41. Alper CA. Inherited structural polymorphism in human C2: evidence for linkage between C2 and Bf. J Exp Med 1976; 144: 1111-5.
42. Monplaisir N, Valette I, Pierre-Louis S, et al. Study of HLA antigens in systemic lupus erythematosus in the French West Indies. Tissue Antigens 1988; 238: 242-6.
43. Schur PH, Marcus-Bagley D, Awdeh Z, Yunis EJ, Alper CA. The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1990; 33: 985-92.
44. Gómez-Reino JJ, Martínez-Laso J, Vicario JL, Paz-Artal M, Aragón F, Martin-Villa M, De Juan F, Arnaiz-Villena A. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers. Immunobiology 1991; 182: 465-71.
45. Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shokawa Y, Hirose S, Terasaki PI, Iwaki Y. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985; 12: 919-23.
46. Savi M, Ferraccioli GF, Neri TM, et al. HLA-DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-70.
47. Gougerot A, Stoppa-Lyonnet D, Poirier JC, Schmid M, Busson M, Marcelli A. HLA markers and complotyes: risk factors in systemic lupus erythematosus. Ann Dermatol Venereol 1987; 114: 329-34.
48. Awdeh ZL, Raum D, Alper CA. Genetic polymorphism of human complement C4 and detection of heterozygotes. Nature 1979; 282: 205-7.